The study specifically looked at whether the use of GLP-1 medications, like liraglutide, semaglutide, or tirzepatide, or SGLT2 inhibitors, such as canagliflozin, dapagliflozin, and empagliflozin, were associated with a decrease in the rates of second strokes, heart attacks, and death
Although nausea and reduced food intake can occur with some GLP-1 receptor agonists, many studies showed reduced alcohol and drug-seeking behaviors even when substances were administered intravenously, suggesting the effects go beyond simple appetite suppression
Typically, patients are started on a lower dosage, and as your doctor receives feedback on your progress they may increase your dosage
Are there safer pain management alternatives if I'm a slow acetaminophen metabolizer